On August 27, the financial report disclosed by Syngenta Group showed that the Group's revenue for the first half of 2026 was US$12.2 billion, down 2% year on year, down 7% at a fixed exchange rate, mainly affected by business restructuring and focusing on high-quality business strategies; EBITDA was US$2.4 billion, up 2% year on year and 3% at fixed exchange rates. Revenue for the second quarter of 2026 was US$5.7 billion, down 7% year on year and down 10% at fixed exchange rates; EBITDA was US$1 billion, down 2% year on year according to reporting standards, and increased 4% at fixed exchange rates.

On August 27, the financial report disclosed by Syngenta Group showed that the Group's revenue for the first half of 2026 was US$12.2 billion, down 2% year on year, down 7% at a fixed exchange rate, mainly affected by business restructuring and focusing on high-quality business strategies; EBITDA was US$2.4 billion, up 2% year on year and 3% at fixed exchange rates. Revenue for the second quarter of 2026 was US$5.7 billion, down 7% year on year and down 10% at fixed exchange rates; EBITDA was US$1 billion, down 2% year on year according to reporting standards, and increased 4% at fixed exchange rates.